Full-Time

Assistant Professor

Tenure Track, Department of Pharmacology and Therapeutics, Pluripotent Stem Cells in Regenerative Medicine, L000066

Posted on 9/18/2025

Deadline 10/31/25
McGill University

McGill University

11-50 employees

University entrepreneurship center and accelerator

No salary listed

Montreal, QC, Canada

In Person

Category
Medical, Clinical & Veterinary (2)
,
Requirements
  • Have a PhD in cell biology, developmental biology, stem cell biology, bioengineering, or a related field with publications demonstrating expertise in pluripotent stem cells (PSCs)
  • Possess relevant postdoctoral experience related to the derivation and use of PSCs for treatment of disease or for disease modeling (e.g., organoids, organotypic slices, or organ-on-chip)
  • Provide evidence of scholarly excellence with the potential to obtain external research funding
  • Demonstrate a commitment to high-quality teaching, inclusive pedagogy, and effective supervision
  • Have a clear vision for their independent research program as it relates to advancing the understanding and the treatment of respiratory diseases in development, childhood, or adulthood
  • Have proven track record of research productivity and effective and synergistic collaboration
  • Fluency in English is essential; a working knowledge of French, or a commitment to acquiring it within few years of appointment is preferred.
Responsibilities
  • Establish and grow an externally-funded innovative research program that complements and integrates with existing strengths within the Department.
  • Train graduate students and postdoctoral fellows and contribute to undergraduate, graduate, and medical teaching within the Department of Pharmacology and Therapeutics and possibly more broadly across the School of Biomedical Sciences (SBMS).
  • Develop the field of human pluripotent stem cells with a focus on deriving cells for personalized medicine approaches in respiratory diseases, including development of technologies for reprogramming of adult cells into induced pluripotent stem cells for differentiation or direct reprogramming.
  • Derive new pluripotent stem cell lines to enable three-dimensional ex vivo disease modeling (organoids, organotypic culture, air-liquid interface culture or organ-on-chip).
  • Engage in areas such as organoids, organotypic culture, air-liquid interface culture or organ-on-chip technologies.
  • Apply in areas like stem cell biology, RNA-based reprogramming, gene editing (CRISPR/Cas9), and deriving endodermal lineages.
Desired Qualifications
  • Researchers working in the broader area of stem cell biology, RNA based reprogramming, gene editing (including CRISPR/Cas9), and/or with expertise in deriving endodermal lineages are encouraged to apply.
  • English language fluency is essential; a working knowledge of French, or a commitment to acquiring it within a few years of appointment is preferred.
  • A demonstrated commitment to equity, diversity, and inclusion is also expected.
  • McGill University is committed to equity and diversity within its community and values academic rigour and excellence. We welcome and encourage applications from racialized persons/visible minorities, women, Indigenous persons, persons with disabilities, ethnic minorities, and persons of minority sexual orientations and gender identities, as well as from all qualified candidates with the skills and knowledge to engage productively with diverse communities.

The McGill Dobson Centre for Entrepreneurship helps people at McGill turn ideas into startups by providing education, mentorship, and practical startup frameworks. It runs programs that take ventures from ideation to fundraising, including the Lean Startup programs, Dobson Bootcamp and Cup, the X-1 Accelerator, and international fundraising tours, with tracks for Life Sciences, Sustainability, and women founders. The Centre draws on university resources and philanthropic support to offer funding readiness, mentorship networks, and access to experienced entrepreneurs and investors, all within a campus-based ecosystem. Its goal is to discover, educate, and cultivate world‑class entrepreneurs and to help them build purposeful companies that contribute to the local and global innovation ecosystem.

Company Size

11-50

Company Stage

Grant

Total Funding

$1.6M

Headquarters

Montreal, Canada

Founded

1995

Simplify Jobs

Simplify's Take

What believers are saying

  • $1.2 billion annual revenue supports major economic contributions.
  • Deregulated programs generated $171.3 million in 2023-2024.
  • 12,602 employees fuel diverse research and educational advancements.

What critics are saying

  • International student cap slashes 30% premium tuition revenue now.
  • Quebec cuts force $45 million budget reduction, 250-500 jobs lost in 2025-26.
  • Federal funding shifts erode basic research grants within 12-24 months.

What makes McGill University unique

  • McGill operates 11 faculties across three world-renowned campuses.
  • Deep Saini leads as President, driving lobbying and innovation partnerships.
  • McGill emphasizes research jobs, libraries, and funding opportunities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Paid Vacation

401(k) Retirement Plan

INACTIVE